Northwestern Mutual Wealth Management
ATRA icon

Northwestern Mutual Wealth Management’s Atara Biotherapeutics ATRA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– – – 3164
2022
Q1 		– Hold
0
– – – 3092
2019
Q2 		– Hold
0
– – – 2489
2019
Q1 		– Hold
0
– – – 2524
2015
Q2 		– Sell
-3
Closed -$3K – 1396
2015
Q1 		$3K Buy
+3
New +$1.98K ﹤0.01% 1281

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baupost Group
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Northwestern Mutual Wealth Management's ATRA Position: Q2 2022 in Review

Northwestern Mutual Wealth Management held its Atara Biotherapeutics (ATRA) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

Northwestern Mutual Wealth Management first reported a position in ATRA in Q1 2015 and has held it in 1 quarter since. The position peaked at $3K in Q1 2015. 134 funds tracked by Wall St. Rank hold ATRA as of Q2 2022.

  • Northwestern Mutual Wealth Management held 0 shares of Atara Biotherapeutics worth $0 as of Q2 2022.
  • Northwestern Mutual Wealth Management left its Atara Biotherapeutics share count unchanged in Q2 2022.
  • Atara Biotherapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2022, its #3164 holding.
  • Northwestern Mutual Wealth Management first reported a position in Atara Biotherapeutics in Q1 2015 and has held it in 1 quarter since.
  • Northwestern Mutual Wealth Management's Atara Biotherapeutics position peaked at $3K in Q1 2015.
  • 134 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.